K. Lieb

Quick facts

Marketed products

• Escitalopram, venlafaxine · Psychiatry/Mental Health
  This combination of escitalopram (an SSRI) and venlafaxine (an SNRI) increases serotonin and norepinephrine levels in the brain to treat depression and anxiety disorders.
• Escitalopram, venlafaxine, lithium · Psychiatry / Mental Health
  This is a combination therapy using escitalopram (SSRI) and venlafaxine (SNRI) to enhance serotonin and norepinephrine reuptake inhibition, with lithium added for mood stabilization and augmentation.

Phase 1 pipeline

• Drug use: modafinil
• Drugs use: methylphenidate

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• K. Lieb portfolio CI brief
• K. Lieb pipeline updates RSS